以质量求发展，以服务铸品牌

Journal of Nursing ›› 2023, Vol. 30 ›› Issue (19): 41-44.doi: 10.16460/j.issn1008-9969.2023.19.041

Previous Articles     Next Articles

  

  • Received:2023-02-03 Online:2023-10-10 Published:2023-11-07

PDF (PC)

211

Like

CLC Number: 

  • R473.57
[1] Baratell C, Turco CGC, Lacidogna G, et al.The role of patient-reported outcomes in outpatients receiving active anti-cancer treatment: impact on patients'quality of life[J]. Supportive Care in Cancer,2019,27(12):4697-4704.DOI:10.1007/s00520-019-04777-2.
[2] 国家药监局药审中心.关于发布《患者报告结局在药物临床研发中应用的指导原则(试行)》的通告(2021年第62号)[EB/OL].[2023-07-22].https://www.cde.org.cn/main/news/viewInfoCommon/c2f79c22e8678241b030c71523eb300c.
[3] Di maio M, Gallo C, Leighl NB, et al. Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized Trials[J].J Clin Oncol,2015,33(8):910-915.DOI:10.1200/JCO.2014.57.9334.
[4] 张鲁敏,顾芬,任皎皎,等.护理领域患者报告结局的研究热点分析[J].医院管理论坛, 2021,38(5): 50-55.DOI:10.3969/j.issn.1671-9069.2021.05.014.
[5] 杨智慧, 缪景霞, 廖荣荣,等.肿瘤免疫治疗护理相关研究的关键词可视化分析[J]. 护理学报, 2023,30(1):12-16.DOI:10.16460/j.issn1008-9969.2023.01.012.
[6] Woo A, Fu T, Popovic M, et al.Comparison of the EORTC STO-22 and the FACT-Ga quality of life questionnaires for patients with gastric cancer[J]. Ann Palliat Med, 2016,5(1): 13-21.DOI: 10.3978/j.issn.2224-5820.2016.01.02.
[7] Blazeby JM, Conroy T, Bottomley A, et al.Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-STO 22, to assess quality of life in patients with gastric cancer[J]. Eur JCancer, 2004,40(15):2260-2268.DOI:10.1016/j.ejca.2004.05.023.
[8] 刘伟琳, 杨舸, 芮煜华, 等. EORTC QLQ-STO22量表对我国胃癌患者有效性的验证[J]. 肿瘤研究与临床, 2016,28(9):595-599.DOI:10.3760/cma.j.issn.1006-9801.2016.09.005.
[9] Hu Y, Vos EL, Baser RE, et al.Longitudinal analysis of Quality-of-Life recovery after gastrectomy for cancer[J]. Ann Surg Oncol,2021,28(1):48-56.DOI:10.1245/s10434-020-09274-z.
[10] Garland SN, Pelletier G, Lawe A, et al.Prospective evaluation of the reliability, validity, and minimally important difference of the functional assessment of cancer therapy-gastric (FACT-Ga) quality-of-life instrument[J]. Cancer, 2011,117(6):1302-1312.DOI:10.1002/cncr.25556.
[11] Debb SM, Arnold B, Perez B,et al.Validation of the FACT-Gastric cancer quality of life questionnaire for use in Spanish-speaking countries[J]. Psycho-Oncology, 2011,20(1): 19-27.DOI:10.1002/pon.1698.
[12] Maeda H, Sato M, Kobayashi M, et al.Validity of the Japanese version of functional assessment of cancer therapy-gastric (FACT-Ga) and its sensitivity to ascites volume change: a retrospective analysis of Japanese clinical trial participants[J]. Supportive Care in Cancer, 2016,24(11): 4515-4521.DOI:10.1007/s00520-016-3290-3.
[13] Schutter K, Schulz C, Middelberg-Bisping K. Impact of gastric cancer treatment on quality of life of patients[J]. Best Pract Res Clin Gastroenterol,2021,50-51:101727.DOI:10.1016/j.bpg.2021.101727.
[14] Zhu Y, Wu X, Wang W, et al.Acupuncture for quality of life in gastric cancer patients undergoing adjuvant chemotherapy[J]. J Pain Symptom Manage, 2022,63(2):210-220.DOI:10.1016/j.jpainsymman.2021.09.009.
[15] Zhou HJ, So JB, Yong WP, et al.Validation of the functional assessment of cancer therapy-gastric module for the Chinese population[J]. Health Qual Life Outcomes, 2012,10: 145.DOI:10.1186/1477-7525-10-145.
[16] 孟祥敏,王倩,闫荣,等.结直肠癌患者报告结局评估工具及临床应用的研究进展[J].中华护理杂志, 2022, 57(9): 1094-1099.DOI:10.3761/j.issn.0254-1769.2022.09.010.
[17] Wang XS, Williams LA, Eng C, et al.Validation and application of a module of the M. D. Anderson Symptom Inventory for measuring multiple symptoms in patients with gastrointestinal cancer (the MDASI-GI)[J]. Cancer, 2010,116(8): 2053-2063.DOI:10.1002/cncr.24920.
[18] Wang XS, Wang Y, Guo H, et al.Chinese version of the M. D. Anderson Symptom Inventory:validation and application of symptom measurement in cancer patients[J]. Cancer, 2004,101(8): 1890-1901.DOI:10.1002/cncr.20448.
[19] Chen R, Yang S, Xu Z, et al.Validation and Application of the Chinese Version of the M.D. Anderson Symptom Inventory Gastrointestinal Cancer Module (MDASI-GI-C)[J]. J Pain Symptom Manage,2019,57(4):820-827.DOI:10.1016/j.jpainsymman.2019.01.007.
[20] 胡月,段培蓓,侯庆梅,等.胃癌术后首次化疗患者症状群与生活质量的研究[J].解放军护理杂志, 2018,35(17): 12-16.DOI: 10.3969/j.issn.1008-9993.2018.17.003.
[21] Maharaj AD, Samoborec S, Evans SM, et al.Patient-reported outcome measures (PROMs) in pancreatic cancer: a systematic review[J]. HPB, 2020,22(2): 187-203.DOI:10.1016/j.hpb.2019.09.002.
[22] Li N, Lu J, Xia D, et al.Serum biomarkers predict adjuvant chemotherapy-associated symptom clusters in radical resected colorectal cancer patients[J]. J Gastrointest Oncol, 2022,13(1): 197-209.DOI:10.21037/jgo-21-904.
[23] Nakada K, Ikeda M, Takahashi M, et al.Characteristics and clinical relevance of postgastrectomy syndrome assessment scale (PGSAS)-45: newly developed integrated questionnaires for assessment of living status and quality of life in postgastrectomy patients[J].Gastric Cancer,2015,18(1): 147-158.DOI:10.1007/s10120-014-0344-4.
[24] Misawa K, Terashlma M, Uenosono Y, et al.Evaluation of postgastrectomy symptoms after distal gastrectomy with Billroth-I reconstruction using the Postgastrectomy Syndrome Assessment Scale-45 (PGSAS-45)[J]. Gastric Cancer, 2015,18(3): 675-681.DOI:10.1007/s10120-014-0407-6.
[25] Kinami S, Nakamura N, Zhiyong J, et al.Severity of postgastrectomy syndrome and quality of life after advanced gastric cancer radical gastrectomy[J].Mol Clin Oncol, 2020,13(2): 133-140.DOI:10.3892/mco.2020.2061.
[26] 袁燕,张楠,王家林.胃癌患者生命质量测定量表及测量结果应用研究进展[J].中华肿瘤防治杂志, 2021, 28(9): 708-712.DOI:10.16073/j.cnki.cjcpt.2021.09.13.
[27] Hu X, Zhao F, Yu H, et al.GC-PROM: validation of a patient-reported outcomes measure for Chinese patients with gastric cancer[J]. BMC Cancer, 2020,20(1): 41.DOI:10.1186/s12885-020-6518-z.
[28] Dueck AC, Mendoza TR, Mitchell SA, et al.Validity and reliability of the US National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)[J].JAMA Oncol, 2015,1(8):1051-1059.DOI:10.1001/jamaoncol.2015.2639.
[29] Yoon J, Sim SH, Kang D, et al.Reliability and validity of the Korean language version of the U.S. National Cancer Institute's Patient-Reported Outcomes Common Terminology Criteria for Adverse Events[J]. J Pain Symptom Manage,2020,59(5):1082-1088.DOI:10.1016/j.jpainsymman.2020.01.015.
[30] Kawguchi T, Azuma K, Sano M, et al.The Japanese version of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE): psychometric validation and discordance between clinician and patient assessments of adverse events[J]. J Patient Rep Outcomes, 2017,2(1):2.DOI:10.1186/s41687-017-0022-5.
[31] Hagelstein V, Ortland I, Wilmer A, et al.Validation of the German patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)[J]. Ann Oncol, 2016,27(12): 2294-2299.DOI:10.1093/annonc/mdw422.
[32] Yang S, Chen L, Liu Y, et al.Validity and reliability of the simplified Chinese patient-reported outcomes version of the common terminology criteria for adverse events[J]. BMC Cancer,2021,21(1):860.DOI:10.1186/s12885-021-08610-0.
[33] Watanabe SM, Nekolaichuk C, Beaumont C, et al.A multicenter study comparing two numerical versions of the Edmonton Symptom Assessment System in palliative care patients[J]. J Pain Symptom Manage, 2011,41(2):456-468.DOI:10.1186/s12885-021-08610-0.
[34] Hui D, Bruera E.The Edmonton Symptom Assessment System 25 years later: past, present, and future developments[J]. J Pain Symptom Manage,2017,53(3):630-643.DOI:10.1016/j.jpainsymman.2016.10.370.
[35] Dong Y, Chen H, Zheng Y, et al.Psychometric validation of the Edmonton Symptom Assessment System in Chinese Patients[J]. J Pain Symptom Manage, 2015,50(5):712-717.DOI:10.1016/j.jpainsymman.2015.05.018.
[36] Merchant SJ, Kong W, Brundage M, et al.Symptom evolution in patients with esophageal and gastric cancer receiving palliative chemotherapy: a population-based study[J].Ann Surg Oncol,2021, 28(1):79-87.DOI:10.1245/s10434-020-09289-6.
[37] Bubis LD, Dellbasiv V, Davis LE, et al.Patient-reported symptoms in metastatic gastric cancer patients in the last 6 months of life[J]. Support Care Cancer, 2021,29(1): 515-524.DOI:10.1007/s00520-020-05501-1.
[38] 刘佳文,赵芬,张艳娜,等.胃癌患者报告结局量表的研制与计量心理学特征考核[J].中国卫生统计,2019,36(3):330-333.
[39] 曹娟,李方,田雅丽,等.早期肺癌术后患者报告结局量表编制及信效度检验[J].护理学杂志, 2023,38(7):35-39.DOI:10.3870/j.issn.1001-4152.2023.07.03.
[1] . [J]. Journal of Nursing, 2024, 31(23): 66-72.
[2] ZHANG Xing-xing, LI Rui-hua, ZHU Mu-lan, LIN Mei-yan, LI Ya-nan, GONG Li-hong, ZENG Hai-ting, ZHEN Li. Best evidence summary for prevention and management of high-output stoma in adult patients with enterostomy [J]. Journal of Nursing, 2024, 31(23): 73-78.
[3] . [J]. Journal of Nursing, 2024, 31(22): 7-11.
[4] . [J]. Journal of Nursing, 2024, 31(20): 73-78.
[5] CAO Chun-ju, WANG Wen, HUANG Mei-ying, HAN Bing, ZENG Mei, LUO Wen-jie, ZHANG Xiao-qin, HUANG Wei-ling, LI Wen-ying, SU Yun-tao, TANG Su-juan. Best evidence summary for management of pruritus in patients with cholestasis [J]. Journal of Nursing, 2024, 31(18): 39-44.
[6] . [J]. Journal of Nursing, 2024, 31(11): 42-47.
[7] SUN Su-ya, CHEN Ya-mei, CHEN Wei-xian, BO Jin, LIU Xiao-hong, HUANG Yan, LIN Meng-yue. Application of cognitive interview in cultural adjustment of Transition Readiness Measure for patients with inflammatory bowel disease in transitional period [J]. Journal of Nursing, 2024, 31(6): 1-5.
[8] . [J]. Journal of Nursing, 2024, 31(6): 18-21.
[9] PAN Ting, CHEN Yan, KONG Fang, ZHANG Ai-ling, CHEN Dan-lei, DING Cheng-liang. Actor-partner effects of subjective well-being and marital adjustment of Crohn's disease patients and Their Spouses [J]. Journal of Nursing, 2024, 31(2): 1-5.
[10] WANG Duo, QIAO Qiu-ge, LIU Ru-ru, ZHANG Mei-ying, LI Ya-wei, GAO Ke-na, GAO Cui, SHI Lei, WANG Wen-yao. Best evidence summary for postoperative oral nutrition management of home-based colorectal cancer patients based on the IMB model [J]. Journal of Nursing, 2023, 30(23): 50-56.
[11] . [J]. Journal of Nursing, 2023, 30(19): 37-40.
[12] ZHANG Chun-xia, Bu Meng-ru, ZHOU Jin. Effect of Mizone and SF-PEG in intestinal preparation for outpatients undergoing colonoscopy [J]. Journal of Nursing, 2023, 30(17): 63-66.
[13] . [J]. Journal of Nursing, 2023, 30(13): 53-58.
[14] ZHOU Meng-juan, ZHU Xiao-li, ZHANG Tai, DUAN Jian-feng, LUO Yu-mei, MA Wei-li, LU Han, SHI Ting-ting, YANG Yi-lin, LI Ting, CHA Yao-lei, ZHAO Yuan. Construction and verification of predictive model for prolonged length of stay in patients with non-severe acute pancreatitis [J]. Journal of Nursing, 2023, 30(9): 7-12.
[15] CAI Wen-wen, ZHANG Xing-xing, YE Min-shan, LUO Yan-xia, RUAN Wei-qing, Li Jia. Construction of nursing sensitive quality indicator system for patients undergoing colonoscopy based on structure-process-outcome model [J]. Journal of Nursing, 2023, 30(6): 1-6.
Viewed
Full text


Abstract

Cited
  Shared   
No Suggested Reading articles found!